These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2967622)

  • 21. Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer.
    Perren TJ; Clayton RN; Blackledge G; Bailey LC; Holder G; Lynch SS; Arkell DG; Cottam J; Farrar D; Young CH
    Cancer Chemother Pharmacol; 1986; 18(1):39-43. PubMed ID: 2944668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
    Reichel RP; Schweppe KW
    Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results].
    Litjens TT; Fernandez del Moral P; van Laarhoven JP; Weil EH; Debruyne FM
    Ned Tijdschr Geneeskd; 1986 Apr; 130(17):787-90. PubMed ID: 3086754
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of prostatic carcinoma with daily subcutaneous injection of the LH-RH analogue, ICI 118630].
    Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Aso Y; Ishigami J; Itatani H; Ohi Y; Ohkawa T
    Hinyokika Kiyo; 1986 Oct; 32(10):1475-88. PubMed ID: 2951985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoladex treatment of symptomatic prostatic carcinoma.
    Holdaway IM; Ibbertson HK; Croxson MS; Harvey V; Boulton J; Knox BS
    Am J Clin Oncol; 1988; 11 Suppl 2():S123-6. PubMed ID: 2977267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group.
    Emtage LA; Trethowan C; Hilton C; Kelly K; Blackledge GR
    Am J Clin Oncol; 1988; 11 Suppl 2():S173-5. PubMed ID: 2977273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical study of an LH-RH agonist (ICI 118.630, Zoladex) in the treatment of prostatic cancer.
    Mauriac L; Coste P; Richaud P; Lamarche P; Mage P; Bonichon F
    Am J Clin Oncol; 1988; 11 Suppl 2():S117-9. PubMed ID: 2977265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
    Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
    Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of prostatic cancer with intranasal administration of LHRH analog, Buserelin (Hoe 766) study of the optimum dosage of intranasal application].
    Niijima T; Kishimoto T; Shimazaki J; Yoshida O; Isurugi K
    Hinyokika Kiyo; 1988 Jul; 34(7):1309-19. PubMed ID: 3140622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renewal timing of long-acting depot luteinizing hormone-releasing hormone agonist (Zoladex) is critical in the treatment of hormone-dependent rat prostatic carcinoma (R3327-H).
    Geldof AA; de Voogt HJ; Rao BR
    Prostate; 1987; 11(3):281-90. PubMed ID: 2960958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.
    Ahmed SR; Grant J; Shalet SM; Howell A; Chowdhury SD; Weatherson T; Blacklock NJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6463):185-7. PubMed ID: 3155636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of Zoladex depot in advanced prostatic cancer with special reference to criteria of response and survival.
    Emtage LA; Perren TJ; Stuart NS; Arkell DG; Wallace DM; Hughes MA; Cottam J; Farrar D; Young CH; Blackledge GR
    Br J Urol; 1987 Nov; 60(5):436-42. PubMed ID: 2962689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer.
    Dijkman GA; del Moral PF; Plasman JW; Kums JJ; Delaere KP; Debruyne FM; Hutchinson FJ; Furr BJ
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):933-6. PubMed ID: 2149507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
    Kaisary AV; Ryan PG; Turkes A; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1988; 260():89-100. PubMed ID: 2966408
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment with the LH-RH agonist (Zoladex depot) in patients with puberty praecox].
    Bassi F; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():33-7. PubMed ID: 2150502
    [No Abstract]   [Full Text] [Related]  

  • 36. Secondary treatment of advanced cancer of the prostate with Zoladex.
    Klarskov P; Lund F; Petersen SE
    Int Urol Nephrol; 1990; 22(4):359-62. PubMed ID: 2146234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
    Shaw RW
    Prog Clin Biol Res; 1990; 323():383-92. PubMed ID: 2137621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with an LHRH analogue in the management of relapsed progressive prostatic cancer.
    Kerle D; Williams G; Ware H; Doble A; Allen J; Bloom SR
    Br J Urol; 1984 Oct; 56(5):495-8. PubMed ID: 6242022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of cancer of the prostate with Zoladex Depot].
    Bouffioux C; Focan C; Désirotte J; Andrianne R; de Leval J; Doupagne M; Franchimont P
    Rev Med Liege; 1986 May; 41(10):438-45. PubMed ID: 2943011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.